Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

While treatment for high blood pressure is not associated with falls, there is some evidence to suggest patients who take blood pressure lowering medications may be more likely to faint or suffer kidney problems which lead to hospital admission, finds a study from ARC OxTV supported researchers.

A nurse helping an elderly person to walk down some stairs

Findings from the study, published in the BMJ, showed that patients taking blood pressure lowering treatment for an average of three years had an 18% increased risk of acute kidney injury and a 28% increased risk of syncope (fainting), but there was no link between treatment and falls or fractures.

The meta-analysis included data from 58 randomised controlled trials involving 280,638 participants and aimed to understand whether those on medication to lower their blood pressure were more likely to report a fall or experience other specific side-effects.

High blood pressure is one of the leading risk factors for cardiovascular disease worldwide, and affects half of people aged over 65 in the UK. For those who are frail or have underlying health conditions, clinical guidelines suggest doctors take a personalised approach to prescribing drugs to lower blood pressure, taking into account the risk that their patient may experience side effects like a fall or kidney injury.

While many meta-analyses of existing research studies review the effectiveness of blood pressure-lowering drugs, few have analysed data on their potential harms or looked for specific side effects.

Lead researcher, Dr James Sheppard, from the University of Oxford’s Nuffield Department of Primary Care Health Sciences, said, “Our analysis dispels the widely held belief that blood pressure-lowering drugs are linked to an increase in the risk of experiencing a fall. However, we did show a link between these drugs and the risk of passing out or experiencing sudden kidney problems, which can have a really major impact on an individual’s quality of life. For relatively fit patients, the risk of these side effects is likely to be very small, but for older people living with lots of long term conditions, the potential harms of treatment should be taken into consideration.

"With clinical guidelines around the world increasingly recommending more intensive treatment for high blood pressure, these findings will help doctors to take a more personalised approach to managing the condition, taking into account both the potential benefit of treatment as well as the harms.”

The team included researchers from the Universities of Oxford, Keele, Cambridge, and Bristol, funded by the Wellcome Trust, Royal Society and the National Institute for Health Research School for Primary Care Research.

READ MORE:

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis
Ali Albasri, Miriam Hattle, Constantinos Koshiaris et al
BMJ 2021;372:n189 doi: https://doi.org/10.1136/bmj.n189

Similar stories

Cathy Creswell Elected Fellow of Academy of Medical Sciences

Cathy Creswell, ARC OxTV Theme lead, Professor of Developmental Clinical Psychology, Departments of Psychiatry and Experimental Psychology, University of Oxford, has been elected a Fellow of the Academy of Medical Sciences.

Self-monitoring of blood pressure does not result in the earlier detection of high blood pressure in pregnancy nor does it improve blood pressure control in those with pregnancy hypertension

Self-monitoring of blood pressure during pregnancy neither results in earlier detection of high blood pressure, nor helps with blood pressure control in those who are pregnant, suggest the results of two new papers based on research from researchers supported by the NIHR ARC OxTV at the University of Oxford and King’s College London.

Excess weight in childhood has significant short- and long-term economic costs

Researchers from Oxford Population Health’s Health Economics Research Centre (HERC) and supported by the NIHR ARC OxTV, have recently published a comprehensive review of the evidence on the economic impacts of childhood excess weight. The results, published in the journal Children, highlight both the significant economic impacts of overweight and obesity in children, and the priority areas for future research.

New study: can a pioneering online programme help parents reduce anxiety in young children?

Oxford Population Health researchers, in part supported by the ARC OxTV, are leading a cost-effectiveness analysis of a new online, parent-led intervention for young children at risk of anxiety disorders.

Three out of four people with heart failure could be diagnosed sooner, potentially improving quality of life and reducing costs to the healthcare system

Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.

Arm and shoulder disability and pain after breast cancer surgery reduced by exercise

The debilitating arm and shoulder disability and pain that some women who have had breast cancer surgery experience as a side effect of their surgery can be reduced by following a physiotherapy-led exercise programme after their operation, a new study has found.